227 related articles for article (PubMed ID: 28576573)
1. Rapid development of vaccines against emerging pathogens: The replication-deficient simian adenovirus platform technology.
Gilbert SC; Warimwe GM
Vaccine; 2017 Aug; 35(35 Pt A):4461-4464. PubMed ID: 28576573
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-vectored Ebola vaccines.
Gilbert SC
Expert Rev Vaccines; 2015; 14(10):1347-57. PubMed ID: 26289977
[TBL] [Abstract][Full Text] [Related]
3. Vaccine development for emerging virulent infectious diseases.
Maslow JN
Vaccine; 2017 Oct; 35(41):5437-5443. PubMed ID: 28216184
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley fever vaccine in mice.
Warimwe GM; Lorenzo G; Lopez-Gil E; Reyes-Sandoval A; Cottingham MG; Spencer AJ; Collins KA; Dicks MD; Milicic A; Lall A; Furze J; Turner AV; Hill AV; Brun A; Gilbert SC
Virol J; 2013 Dec; 10():349. PubMed ID: 24304565
[TBL] [Abstract][Full Text] [Related]
5. Immunology and evolvement of the adenovirus prime, MVA boost Ebola virus vaccine.
Zhou Y; Sullivan NJ
Curr Opin Immunol; 2015 Aug; 35():131-6. PubMed ID: 26247875
[TBL] [Abstract][Full Text] [Related]
6. Rethinking the Response to Emerging Microbes: Vaccines and Therapeutics in the Ebola Era--a Conference at Harvard Medical School.
Knipe DM; Whelan SP
J Virol; 2015 Aug; 89(15):7446-8. PubMed ID: 25995250
[TBL] [Abstract][Full Text] [Related]
7. Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens.
Fathi A; Dahlke C; Addo MM
Hum Vaccin Immunother; 2019; 15(10):2269-2285. PubMed ID: 31368826
[TBL] [Abstract][Full Text] [Related]
8. Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
Terasaki K; Tercero BR; Makino S
Virus Res; 2016 May; 216():55-65. PubMed ID: 26022573
[TBL] [Abstract][Full Text] [Related]
9. Rift Valley fever vaccines: an overview of the safety and efficacy of the live-attenuated MP-12 vaccine candidate.
Ikegami T
Expert Rev Vaccines; 2017 Jun; 16(6):601-611. PubMed ID: 28425834
[TBL] [Abstract][Full Text] [Related]
10. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
Suschak JJ; Schmaljohn CS
Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
[TBL] [Abstract][Full Text] [Related]
11. CEPI: Driving Progress Toward Epidemic Preparedness and Response.
Gouglas D; Christodoulou M; Plotkin SA; Hatchett R
Epidemiol Rev; 2019 Jan; 41(1):28-33. PubMed ID: 31673694
[TBL] [Abstract][Full Text] [Related]
12. Global research trends of World Health Organization's top eight emerging pathogens.
Sweileh WM
Global Health; 2017 Feb; 13(1):9. PubMed ID: 28179007
[TBL] [Abstract][Full Text] [Related]
13. Vaccines for emerging infectious diseases: Lessons from MERS coronavirus and Zika virus.
Maslow JN
Hum Vaccin Immunother; 2017 Dec; 13(12):2918-2930. PubMed ID: 28846484
[TBL] [Abstract][Full Text] [Related]
14. One Health approach to Rift Valley fever vaccine development.
Kortekaas J
Antiviral Res; 2014 Jun; 106():24-32. PubMed ID: 24681125
[TBL] [Abstract][Full Text] [Related]
15. Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates.
Smith DR; Johnston SC; Piper A; Botto M; Donnelly G; Shamblin J; Albariño CG; Hensley LE; Schmaljohn C; Nichol ST; Bird BH
PLoS Negl Trop Dis; 2018 May; 12(5):e0006474. PubMed ID: 29742102
[TBL] [Abstract][Full Text] [Related]
16. Towards a vaccine against Ebola virus.
Geisbert TW; Jahrling PB
Expert Rev Vaccines; 2003 Dec; 2(6):777-89. PubMed ID: 14711361
[TBL] [Abstract][Full Text] [Related]
17. INFECTIOUS DISEASE. Camel vaccine offers hope to stop MERS.
Kupferschmidt K
Science; 2015 Dec; 350(6267):1453. PubMed ID: 26680169
[No Abstract] [Full Text] [Related]
18. Virology. New vaccine and treatment excite Ebola researchers.
Enserink M
Science; 2003 Nov; 302(5648):1141-2. PubMed ID: 14615510
[No Abstract] [Full Text] [Related]
19. Vaccination of alpacas against Rift Valley fever virus: Safety, immunogenicity and pathogenicity of MP-12 vaccine.
Rissmann M; Ulrich R; Schröder C; Hammerschmidt B; Hanke D; Mroz C; Groschup MH; Eiden M
Vaccine; 2017 Jan; 35(4):655-662. PubMed ID: 28012779
[TBL] [Abstract][Full Text] [Related]
20. Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs.
Busquets N; Lorenzo G; López-Gil E; Rivas R; Solanes D; Galindo-Cardiel I; Abad FX; Rodríguez F; Bensaid A; Warimwe G; Gilbert SC; Domingo M; Brun A
Antiviral Res; 2014 Aug; 108():165-72. PubMed ID: 24933081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
